The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
3,000 jobs Number of planned job losses
Announcement Date
1 February 2007
Employment effect (start)
1 February 2007
Foreseen end date
31 December 2010
Description
On 1 Febuary 2007, the British-Swedish pharmaceutical company AstraZeneca announced cost-saving plans to secure future investments and acquisitions. Plans foresee the loss of 3,000 out of 14,000 manufacturing jobs worldwide. AstraZeneca, which employs a total workforce of 65,000 worldwide, holds 14 manufacturing plants in 19 countries. No precise information on the affected plants was given. AstraZeneca's major competititors Merck and Pfizer have also adopted cost-saving programmes. In 2005, Merck announced the loss of 7,000 jobs worldwide; very recently (January 2007) Pfizer revealed its plans to cut 10,000 jobs.
Sources
2 February 2007: Financial Times Deutschland
Citation
Eurofound (2007), Astra Zeneca, Internal restructuring in World, factsheet number 64877, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64877.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
